Brief: Fortress Biotech Inc Files Prospectus Relates To Resale Of 2.4 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
20/06/2024 22:11
June 20 (Reuters) - Fortress Biotech Inc FBIO.O :
* FORTRESS BIOTECH INC FILES PROSPECTUS RELATES TO RESALE OF
2.4
MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS - SEC
FILING
Source text for Eikon: ID:n0001104659-24-073375
Further company coverage: FBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fortress Biotech
See all newsFortress Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Fortress Biotech Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Fortress Biotech And Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Fortress Biotech Q1 net income jumps on PRV sale
Brief: Journey Medical Corporation Secures Contract With Third Major Gpo For Emrosi